" class="no-js "lang="en-US"> ASCO GU Archives - Pharmtech Focus
Wednesday, February 01, 2023

Sort by:

Date

Top Post

NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition

The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]

Telix Pharmaceuticals ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU Along with Theranostic Pipeline Advances

Telix Pharmaceuticals has announced that the completed pivotal Phase III ZIRCON study of TLX250-CDx in […]

  1. Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers Read more
  2. Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC) Read more
  3. AviadoBio Announces Appointment of Jeff Goater as Chair of the Board of Directors Read more
  4. Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia Read more
  5. Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, as Chief Medical Officer Read more